NDC11 60505058901
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60505-0589-01 | 60505-0589 |
| 60505-0589-1 | 60505-0589 |
| 60505-589-01 | 60505-589 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Apotex Corp. | 268c3f6b-8798-7987-3b8c-7b7f560af5d7 | 2026-04-23 | Warnings, Adverse reactions | 60505-0589-1 60505-0589 60505058901 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.